Drugs / Desflurane
last change 3 days ago re-read 2 minutes ago

Desflurane

Other / unclassified targets CDC42, CLOCK, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9 via activation

Developed for
delirium · coronary artery disorder · aortic valve stenosis · cognitive disorder · ischemic disease · pediatric acute respiratory distress syndrome · subjective cognitive decline · acute lung injury
+1 more · non-small cell lung carcinoma
Investigated by
Yonsei University · Kangbuk Samsung Hospital · Seoul National University Hospital · Baxter Healthcare Corporation · Beijing Tiantan Hospital · Cantonal Hospital of St. Gallen
+79 more · Medical University of Gdansk · Medical University of Vienna · Ruhr University of Bochum · University of Zurich · Ain Shams University · Ajou University School of Medicine · All India Institute of Medical Sciences · All India Institute of Medical Sciences, Raebareli, UP · Aristotle University Of Thessaloniki · Assistance Publique - Hôpitaux de Paris · Ataturk University · Baskent University Ankara Hospital · Begoña Quintana Villamandos · Beijing Chao Yang Hospital · C. R. Bard · Centre Hospitalier Universitaire Vaudois · Chiang Mai University · Chih-Cheng Hung · Children's Hospital Medical Center, Cincinnati · DongGuk University · Eye & ENT Hospital of Fudan University · Fondation Apicil · Gachon University Gil Medical Center · Gangnam Severance Hospital · Georgia Tsaousi · German Federal Ministry of Education and Research · Harran University · Huazhong University of Science and Technology · Inje University · Insel Gruppe AG, University Hospital Bern · Kantonsspital Münsterlingen · Kantonsspital Winterthur KSW · Keimyung University Dongsan Medical Center · Kocaeli City Hospital · Konkuk University Medical Center · Konya City Hospital · Ludwig-Maximilians - University of Munich · Mahidol University · Malaysian Society of Anaesthesiologists · Medical University Innsbruck · Menoufia University · Mercy Facial Plastic Surgery Center · Muğla Sıtkı Koçman University · Nanjing Medical University · National and Kapodistrian University of Athens · Nobuyuki Katori · Ohio State University · Prince of Songkla University · Pusan National University Yangsan Hospital · RWTH Aachen University · Saint Savvas Anticancer Hospital · Sefako Makgatho Health Sciences University · Shengjing Hospital · Sichuan Provincial People's Hospital · Stony Brook University · Tam Anh Research Institute · Tam Anh TP. Ho Chi Minh General Hospital · The Catholic University of Korea · The Cleveland Clinic · The Second Affiliated Hospital of Chongqing Medical University · Theodor Bilharz Research Institute · Tianjin First Central Hospital · Tokyo Women's Medical University · Trakya University · Triemli Hospital · Ufuk University · Universiti Sains Malaysia · University Hospital Hradec Kralove · University Hospital, Basel, Switzerland · University Hospital, Clermont-Ferrand · University of Malaya · University of Melbourne · Vita-Salute San Raffaele University · West China Hospital · all 85 on the full record

Regulatory milestones approvals, filings & regulatory actions · 2 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansion US (FDA) SUPRANE 2006-12-15 fda.gov
Approved US (FDA) SUPRANE 1992-09-18 fda.gov

Trials 94 · started per year

today
US approved 1992
1
2
2
1
2
4
2
5
14
6
11
7
2
3
2
6
4
8
2
8
2
1992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 02 trials
Phase 0 NCT06241131 Mar → Dec 2024 Sichuan Provincial People's Hospital Unknown No outcome recorded
Phase 0 NCT05246371 Jun → Nov 2021 Ain Shams University Unknown No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT04771962 Jan 2020 → Dec 2021 Universiti Sains Malaysia Completed No outcome recorded
Phase 22 trials
Phase 2 NCT02559297 Aug 2015 → Jun 2017 Mahidol University Completed No outcome recorded
Phase 2 NCT02036736 Apr 2013 → Dec 2014 Assistance Publique - Hôpitaux de Paris Completed No outcome recorded
Phase 2/31 trial
Phase 2/3 NCT00762372 Feb → Aug 2008 Baxter Healthcare Corporation Completed No outcome recorded
Phase 37 trials
Phase 3 NCT07116733 Oct 2025 → Dec 2028 expected Xijing Hospital Recruiting No outcome recorded
Phase 3 NCT03618082 Jun 2019 → May 2022 University Hospital, Clermont-Ferrand Unknown No outcome recorded
Phase 3 NCT02872389 Aug → Dec 2016 Kangbuk Samsung Hospital Completed No outcome recorded
Phase 3 NCT02830243 Jul → Oct 2016 Kangbuk Samsung Hospital Completed No outcome recorded
Phase 3 NCT02698514 Feb → Jul 2016 Kangbuk Samsung Hospital Completed No outcome recorded
Phase 3 NCT02609802 Nov 2015 → Jul 2016 musculoskeletal system disorder Kangbuk Samsung Hospital Completed No outcome recorded
Phase 3 NCT02322502 Feb 2015 → Feb 2016 RWTH Aachen University Completed No outcome recorded
Phase 425 trials
Phase 4 NCT07123870 Jul → Oct 2025 overdue Kocaeli City Hospital Recruiting No outcome recorded
Phase 4 NCT06779890 May 2025 → Sep 2026 expected brain edema Georgia Tsaousi Recruiting No outcome recorded
Phase 4 NCT07359508 Jan 2024 → Jun 2025 All India Institute of Medical Sciences Completed No outcome recorded
Phase 4 NCT05990790 Sep 2023 → Dec 2027 expected delirium Medical University of Vienna Recruiting No outcome recorded
Phase 4 NCT05783518 Mar → Oct 2023 biliary atresia, pediatric acute respiratory distress syndrome Tianjin First Central Hospital Unknown No outcome recorded
Phase 4 NCT05331027 May 2022 → Jun 2023 delirium Medical University of Vienna Completed No outcome recorded
Phase 4 NCT04541823 May 2021 → Dec 2022 delirium Beijing Chao Yang Hospital Unknown No outcome recorded
Phase 4 NCT03917186 Sep 2017 → Dec 2020 kidney failure Begoña Quintana Villamandos Completed No outcome recorded
Phase 4 NCT03194074 Aug 2017 → Jun 2019 cognitive disorder Eye & ENT Hospital of Fudan University Unknown No outcome recorded
Phase 4 NCT03209193 Jul 2017 → Nov 2019 Seoul National University Hospital Completed No outcome recorded
Phase not applicable56 trials
NCT07511634 Apr → Dec 2026 expected Pusan National University Yangsan Hospital Not yet recruiting No outcome recorded
NCT07295158 Mar → Jul 2026 overdue Konya City Hospital Recruiting No outcome recorded
NCT07239479 Dec 2025 → Dec 2026 expected colorectal neoplasm Tam Anh Research Institute Recruiting No outcome recorded
NCT07271472 Dec 2025 → May 2026 Ataturk University Completed No outcome recorded
NCT07016308 Jun → Nov 2025 Harran University Completed No outcome recorded
NCT06772558 Feb → May 2025 overdue avascular necrosis, benign prostatic hyperplasia, cholecystitis, coronary artery disorder +1 Xiaguang Duan Not yet recruiting No outcome recorded
NCT06759623 Jan 2025 → Apr 2026 overdue obesity disorder Medical University of Gdansk Recruiting No outcome recorded
NCT06252207 Dec 2023 → Mar 2026 The Cleveland Clinic Withdrawn No outcome recorded
NCT06123624 Nov 2023 → Aug 2024 spinal cord disorder Ajou University School of Medicine Unknown No outcome recorded
NCT06207344 Oct 2023 → Dec 2024 The Second Affiliated Hospital of Chongqing Medical University Unknown No outcome recorded
Also used as a comparator or background therapy in 86 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/21 trial
Phase 1/2 NCT01700907 Comparator Aug 2012 → Feb 2013 Sapporo Medical University Completed No outcome recorded
Phase 24 trials
Phase 2 NCT05502458 Comparator Dec 2020 → Aug 2022 hepatocellular carcinoma Zhejiang Cancer Hospital Completed No outcome recorded
Phase 2 NCT02971254 Comparator Dec 2016 → Jan 2019 Down syndrome Asklepieion Voulas General Hospital Completed No outcome recorded
Phase 2 NCT03727607 Comparator Jan 2016 → Dec 2017 obesity disorder Ostfold Hospital Trust Completed No outcome recorded
Phase 2 NCT01696630 Comparator Oct 2012 → Jul 2014 colorectal cancer Centre Leon Berard Completed No outcome recorded
Phase 33 trials
Phase 3 NCT07289945 Comparator Sep 2024 → Apr 2025 cognitive disorder Hopital Charles Nicolle Completed No outcome recorded
Phase 3 NCT01219881 Comparator Sep 2010 → Oct 2012 Ohio State University Completed No outcome recorded
Phase 3 NCT00219856 Comparator Aug 2004 → Mar 2006 Rennes University Hospital Completed No outcome recorded
Phase 436 trials
Phase 4 NCT06457958 Comparator Jun → Aug 2025 cholecystitis Kocaeli City Hospital Withdrawn No outcome recorded
Phase 4 NCT06330038 Comparator Aug 2024 → Dec 2028 expected non-small cell lung carcinoma Samsung Medical Center Recruiting No outcome recorded
Phase 4 NCT05172739 Comparator Oct 2021 → Nov 2025 overdue chronic pain syndrome, non-small cell lung carcinoma, substance-related disorder University of Crete Recruiting No outcome recorded
Phase 4 NCT04717102 Comparator Apr 2021 → Mar 2024 Changi General Hospital Completed No outcome recorded
Phase 4 NCT04894864 Comparator Oct 2020 → Sep 2026 expected abdominal aortic aneurysm University of Crete Recruiting No outcome recorded
Phase not applicable42 trials
NCT07525648 Comparator Apr → May 2026 intracranial hypertension Medipol University Completed No outcome recorded
NCT07440758 Comparator Mar → Jul 2026 overdue gallbladder disorder Kayseri City Hospital Recruiting No outcome recorded
NCT07304479 Comparator May 2025 → Jan 2026 overdue National and Kapodistrian University of Athens Recruiting No outcome recorded
NCT07363681 Comparator Oct 2024 → Feb 2026 overdue nephrolithiasis Bakirkoy Dr. Dr. Sadi Konuk Research and Training Hospital Recruiting No outcome recorded
NCT06387836 Comparator Apr 2024 → May 2025 subjective cognitive decline Shanghai Zhongshan Hospital Completed No outcome recorded

Evidence & citations 17 cited values

Every value below carries the sentence it was read from. 181 sources stand behind the page.

FieldValueCited text
Known as desflurane “The GAS group will receive one or more volatile anesthetics (sevoflurane, desflurane, or isoflurane) for induction and maintenance of anesthesia during the surgery.” NCT06330038
181

“During the operation, patients are treated with remifentanil, cisatracurium, and desflurane inhalation at 0.5-1.0 minimum alveolar concentration (MAC).” NCT05550714

“During maintenance, desflurane 5-7% (MAC 1-1.3) and TCI remifentanil at a Ce of 1.5-3 ng/mL will be administered, targeting a BIS value between 40-60.” NCT07271472

“if inhalational maintenance of anesthesia is used it will be achieved with sevoflurane 1% to 2% or desflurane 3% to 6% end-tidal concentration” NCT03263117

“General anesthesia for patients will be inducted and maintained with desflurane inhalation and remifentanil infusion.” NCT04983966

“Patients will be randomized to Sevoflurane or Desflurane as the single volatile anesthetics for general anesthesia.” NCT04395248

“Maintenance of general anesthesia with volatile agent (sevoflurane, desflurane, or isoflurane)” NCT03034096

“Patients undergoing anesthesia for bariatric surgery with desflurane as a volatile agent.” NCT06759623

“The gas flow rate of Desflurane group is 2 L/min, include 50% O2 and 4~5% Desflurane.” NCT02909413

Desflurane , introduced into clinical practice in 1990 as an inhaled anesthetic” NCT07116733

“Sevoflurane or desflurane for induction and maintenance of anesthesia” NCT04503148

“Anesthesia maintenance: Desflurane set at approximately 1 MAC” NCT04894864

“Anesthesia maintenance: Desflurane 6-8 vol%” NCT05557253

Desflurane, Morphine, Paracetamol” NCT05172739

“volatile anesthesia (desflurane)” NCT04077827

“* Desflurane for maintenance,” NCT07337135

“OFA with DesfluraneNCT07568938

DesfluraneNCT07568938

NCT01870011

NCT02213718

NCT05148637

NCT03540030

NCT07525648

NCT03756961

NCT03447691

NCT02717780

NCT07239479

NCT03194074

NCT00983918

NCT03539003

NCT07363681

NCT03618082

NCT02504138

NCT05088252

NCT05774366

NCT04541823

NCT01083953

NCT03763305

NCT02283866

NCT03587779

NCT01886664

NCT00815269

NCT04036487

NCT01235143

NCT02726620

NCT00528515

NCT01270620

NCT04775212

NCT07359508

NCT04104334

NCT02925611

NCT02199314

NCT01132157

NCT04771962

NCT01219881

NCT04983966

NCT00762372

NCT01486953

NCT02019797

NCT03029715

NCT04188314

NCT05185167

NCT03006250

NCT02625181

NCT02191371

NCT03570164

NCT07304479

NCT06457958

NCT02105610

NCT04039854

NCT02515968

NCT03099616

NCT02922660

NCT01937104

NCT02412150

NCT01936545

NCT04074460

NCT03100604

NCT06241131

NCT03209193

NCT03016234

NCT04447105

NCT02756715

NCT06176144

NCT02826902

NCT04691128

NCT02830243

NCT05246371

NCT07295158

NCT01436799

NCT02916407

NCT02617680

NCT02342509

NCT02410460

NCT03864276

NCT05502458

NCT07016308

NCT02971254

NCT04767503

NCT02520947

NCT02458547

NCT03417518

NCT07511634

NCT04226625

NCT01696630

NCT04805775

NCT02212340

NCT02834845

NCT05951686

NCT01199237

NCT06207344

NCT01985854

NCT03435003

NCT03504033

NCT05331027

NCT01171833

NCT02406300

NCT07289945

NCT02631525

NCT03727607

NCT02609802

NCT06387836

NCT03860129

NCT05414721

NCT00219856

NCT00434382

NCT04238806

NCT01549873

NCT01700907

NCT02987218

NCT00244517

NCT04474600

NCT02335151

NCT01167803

NCT06772558

NCT02698514

NCT03917186

NCT05990790

NCT01125982

NCT05866315

NCT02096224

NCT01202162

NCT06123624

NCT01443572

NCT01833676

NCT01878656

NCT05783518

NCT01924871

NCT04717102

NCT00400790

NCT02643615

NCT01310582

NCT05465330

NCT02470442

NCT01760018

NCT02149628

NCT02003768

NCT04287842

NCT07123870

NCT03659539

NCT04645316

NCT02079064

NCT02003885

NCT02559297

NCT03848780

NCT02872389

NCT00446212

NCT06252207

NCT03152981

NCT02174575

NCT02324283

NCT03996148

NCT02036736

NCT03259672

NCT02709863

NCT01452256

NCT06779890

NCT07440758

NCT02322502

NCT03729011

NCT02379546

NCT02379715

Known as desflurane (Suprane(R), Baxter Healthcare) desflurane (Suprane(R), Baxter Healthcare)NCT02191371
Known as Desflurano ChEMBL registry synonym — accepted as the source's own label CHEMBL1200733
Known as I-653 ChEMBL registry synonym — accepted as the source's own label CHEMBL1200733
Known as Suprane ChEMBL registry synonym — accepted as the source's own label CHEMBL1200733
Known as Suprane (desflurane, USP) Suprane (desflurane, USP)NCT01235143
Action Activate “Potassium channel subfamily K member 18 opener” CHEMBL1200733
4

“Potassium channel subfamily K member 10 opener” CHEMBL1200733

“Potassium channel subfamily K member 9 opener” CHEMBL1200733

“Potassium channel subfamily K member 3 opener” CHEMBL1200733

“Potassium channel subfamily K member 2 opener” CHEMBL1200733

Action Inhibit “The volatile anesthetics such as sevoflurane and desflurane are known to block the muscarinic receptor in different ways.” NCT02096224
Modality Other / unclassified “Desflurane is the new volatile anesthetic agent” NCT01235143
Route Inhaled Inhaled desflurane aiming an alveolar concentration of 4 to 6 per cent.” NCT00219856
Target CDC42 “by modulating Cdc42 and Clock proteins” NCT06772558
Target CLOCK “by modulating Cdc42 and Clock proteins” NCT06772558
Target KCNK10 “Potassium channel subfamily K member 10 opener” CHEMBL1200733
Target KCNK18 “Potassium channel subfamily K member 18 opener” CHEMBL1200733
Target KCNK2 “Potassium channel subfamily K member 2 opener” CHEMBL1200733
Target KCNK3 “Potassium channel subfamily K member 3 opener” CHEMBL1200733
Target KCNK9 “Potassium channel subfamily K member 9 opener” CHEMBL1200733